NEW YORK (GenomeWeb News) – Aviir today announced the completion of a $10 million tranche, completing a financing round started in December 2011 that raised a total of $30 million.

Proceeds will be used to build out the Irvine, Calif.-based firm's commercial infrastructure, speed up its nationwide commercial launch, and expand third-party reimbursement efforts, it said. It also plans to use proceeds to begin distribution of the company's cardiac risk test outside of the US, and to create additional laboratory testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.